SLU-PP-332 AND RELATED ERR\u03b1 AGONISTS: A FOCUSED MINIREVIEW OF METABOLIC REGULATION, AND THERAPEUTIC POTENTIAL<\/title><secondary-title>Universal Journal of Pharmaceutical Research<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.22270\/ujpr.v10i3.1355<\/electronic-resource-num><urls><related-urls><url>https:\/\/core.ac.uk\/download\/670449627.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Hamid Nasri<\/author><\/authors><\/contributors><titles><title>New hopes on "SLU-PP-332" as an effective agent for weight loss with indirect kidney protection efficacy; a nephrology point of view<\/title><secondary-title>Journal of Renal Endocrinology<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.34172\/jre.2024.25143<\/electronic-resource-num><urls><related-urls><url>https:\/\/jrenendo.com\/PDF\/jre-10-e25143.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bhupendra M. Mahale<\/author><author>Akshata M. Girase<\/author><author>Maheshwari M. Mahale<\/author><\/authors><\/contributors><titles><title>Unlocking the potential: SLU-PP-332 and the future of exercise Enhancement and Metabolic health<\/title><secondary-title>Research Journal of Science and Technology<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.52711\/2349-2988.2024.00047<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>M\u00f6ller T<\/author><author>Krug O<\/author><author>Thevis M<\/author><\/authors><\/contributors><titles><title>In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential.<\/title><secondary-title>Rapid communications in mass spectrometry : RCM<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1002\/rcm.70039<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC12835572?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Okda HE<\/author><author>Zhao P<\/author><author>Hayes M et al.<\/author><\/authors><\/contributors><titles><title>Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling.<\/title><secondary-title>International journal of biological macromolecules<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1016\/j.ijbiomac.2026.151450<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13112601?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>B.-A. Hagiu<\/author><\/authors><\/contributors><titles><title>Can SLU-PP-332 be a new drug to prevent COVID-19?<\/title><secondary-title>Medical Hypotheses<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1016\/j.mehy.2024.111362<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Billon C<\/author><author>Sitaula S<\/author><author>Banerjee S et al.<\/author><\/authors><\/contributors><titles><title>Synthetic ERR\u03b1\/\u03b2\/\u03b3 Agonist Induces an ERR\u03b1-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.<\/title><secondary-title>ACS chemical biology<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1021\/acschembio.2c00720<\/electronic-resource-num><urls><related-urls><url>https:\/\/core.ac.uk\/download\/650176731.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Avliyakulov NK<\/author><author>Sobolevsky T<\/author><author>Ahrens E<\/author><\/authors><\/contributors><titles><title>Analysis and Identification of In\u00a0Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERR\u03b1\/\u03b2\/\u03b3 Agonist for Doping-Control Purposes.<\/title><secondary-title>Drug testing and analysis<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1002\/dta.70035<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>de Souza-Lima J<\/author><author>Astrosa-Martin BD<\/author><author>Galaz-Rodr\u00edguez CA et al.<\/author><\/authors><\/contributors><titles><title>[Pharmacological Activation of ERR\u03b1\/\u03b2\/\u03b3 as an Exercise Mimetic: Potential Therapeutic Applications].<\/title><secondary-title>Revista medica de Chile<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.4067\/s0034-98872026000200237<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.4067\/s0034-98872026000200237<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Weiyi Xu<\/author><author>Cyrielle Billon<\/author><author>Hui Li et al.<\/author><\/authors><\/contributors><titles><title>Abstract 9682: The Cardiac Protective Effects of Novel Synthetic Pan-Estrogen Related Receptor Agonists Slu-pp-332 and Slu-pp-915<\/title><secondary-title>Circulation<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1161\/circ.144.suppl_1.9682<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bonanni R<\/author><author>Falvino A<\/author><author>Matticari A et al.<\/author><\/authors><\/contributors><titles><title>Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study.<\/title><secondary-title>Frontiers in physiology<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.3389\/fphys.2025.1616693<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2025.1616693\/full<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Billon C<\/author><author>Schoepke E<\/author><author>Avdagic A et al.<\/author><\/authors><\/contributors><titles><title>A Synthetic ERR Agonist Alleviates Metabolic Syndrome.<\/title><secondary-title>The Journal of pharmacology and experimental therapeutics<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1124\/jpet.123.001733<\/electronic-resource-num><urls><related-urls><url>https:\/\/jpet.aspetjournals.org\/content\/jpet\/early\/2023\/09\/22\/jpet.123.001733.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Xu W<\/author><author>Billon C<\/author><author>Li H et al.<\/author><\/authors><\/contributors><titles><title>Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.<\/title><secondary-title>Circulation<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1161\/CIRCULATIONAHA.123.066542<\/electronic-resource-num><urls><related-urls><url>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10842599\/pdf\/nihms-1941033.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>R\u00f6dlistade arter i Sverige 2025<\/title><secondary-title>SLU Artdatabanken rapporterar<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.54612\/a.6scftkgu7u<\/electronic-resource-num><urls><related-urls><url>https:\/\/pub.epsilon.slu.se\/id\/eprint\/39759\/contents<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mats S\u00f6derstr\u00f6m<\/author><author>Bruno Morandin Figueiredo et al.<\/author><\/authors><\/contributors><titles><title>Developments in proximal crop sensing for precision agriculture<\/title><secondary-title>Burleigh Dodds Series in Agricultural Science<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.19103\/as.2025.0152.02<\/electronic-resource-num><urls><related-urls><url>https:\/\/pub.epsilon.slu.se\/38800\/1\/soderstrom-m-et-al-20251111.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Doing More Good<\/author><author>SLU<\/author><author>Ger\u00e8ncia d'\u00c0rea d'Economia i Promoci\u00f3 Econ\u00f2mica<\/author><\/authors><\/contributors><titles><title>Conveni de col\u00b7laboraci\u00f3 entre l'Ajuntament de Barcelona i Doing More Good Slu per al projecte Congreso Europeo de Sports Business: Sportbiz Europe Barcelona<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><urls><related-urls><url>https:\/\/core.ac.uk\/download\/596352815.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Wang XX<\/author><author>Myakala K<\/author><author>Libby AE et al.<\/author><\/authors><\/contributors><titles><title>Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney.<\/title><secondary-title>The American journal of pathology<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1016\/j.ajpath.2023.07.008<\/electronic-resource-num><urls><related-urls><url>http:\/\/ajp.amjpathol.org\/article\/S0002944023003218\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Billon C<\/author><author>Appourchaux K<\/author><author>C\u00f4t\u00e9 I et al.<\/author><\/authors><\/contributors><titles><title>An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.<\/title><secondary-title>The Journal of pharmacology and experimental therapeutics<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1016\/j.jpet.2025.103787<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Sophia Collins<\/author><author>Amanda Kohne<\/author><author>Mary Otten et al.<\/author><\/authors><\/contributors><titles><title>SLU DOES: SLU Drones for Outreach and Education in STEM - A Framework for Community Engagement<\/title><secondary-title>AIAA SCITECH 2024 Forum<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.2514\/6.2024-0054<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>\u00c5rsber\u00e4ttelse 2025 : SLU Centrum f\u00f6r biologisk bek\u00e4mpning<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.54612\/a.70g1crqa39<\/electronic-resource-num><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>Mostafa Essam Eissa<\/author><\/authors><\/contributors>SLU-PP-332 AND RELATED ERR\u03b1 AGONISTS: A FOCUSED MINIREVIEW OF METABOLIC REGULATION, AND THERAPEUTIC POTENTIAL<\/title><secondary-title>Universal Journal of Pharmaceutical Research<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.22270\/ujpr.v10i3.1355<\/electronic-resource-num><urls><related-urls><url>https:\/\/core.ac.uk\/download\/670449627.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Hamid Nasri<\/author><\/authors><\/contributors><titles><title>New hopes on "SLU-PP-332" as an effective agent for weight loss with indirect kidney protection efficacy; a nephrology point of view<\/title><secondary-title>Journal of Renal Endocrinology<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.34172\/jre.2024.25143<\/electronic-resource-num><urls><related-urls><url>https:\/\/jrenendo.com\/PDF\/jre-10-e25143.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bhupendra M. Mahale<\/author><author>Akshata M. Girase<\/author><author>Maheshwari M. Mahale<\/author><\/authors><\/contributors><titles><title>Unlocking the potential: SLU-PP-332 and the future of exercise Enhancement and Metabolic health<\/title><secondary-title>Research Journal of Science and Technology<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.52711\/2349-2988.2024.00047<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>M\u00f6ller T<\/author><author>Krug O<\/author><author>Thevis M<\/author><\/authors><\/contributors><titles><title>In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping Potential.<\/title><secondary-title>Rapid communications in mass spectrometry : RCM<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1002\/rcm.70039<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC12835572?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Okda HE<\/author><author>Zhao P<\/author><author>Hayes M et al.<\/author><\/authors><\/contributors><titles><title>Chemical optimization of the exercise mimetic SLU-PP-332 enables insight into estrogen-related receptor signaling.<\/title><secondary-title>International journal of biological macromolecules<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1016\/j.ijbiomac.2026.151450<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC13112601?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>B.-A. Hagiu<\/author><\/authors><\/contributors><titles><title>Can SLU-PP-332 be a new drug to prevent COVID-19?<\/title><secondary-title>Medical Hypotheses<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1016\/j.mehy.2024.111362<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Billon C<\/author><author>Sitaula S<\/author><author>Banerjee S et al.<\/author><\/authors><\/contributors><titles><title>Synthetic ERR\u03b1\/\u03b2\/\u03b3 Agonist Induces an ERR\u03b1-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity.<\/title><secondary-title>ACS chemical biology<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1021\/acschembio.2c00720<\/electronic-resource-num><urls><related-urls><url>https:\/\/core.ac.uk\/download\/650176731.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Avliyakulov NK<\/author><author>Sobolevsky T<\/author><author>Ahrens E<\/author><\/authors><\/contributors><titles><title>Analysis and Identification of In\u00a0Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERR\u03b1\/\u03b2\/\u03b3 Agonist for Doping-Control Purposes.<\/title><secondary-title>Drug testing and analysis<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1002\/dta.70035<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>de Souza-Lima J<\/author><author>Astrosa-Martin BD<\/author><author>Galaz-Rodr\u00edguez CA et al.<\/author><\/authors><\/contributors><titles><title>[Pharmacological Activation of ERR\u03b1\/\u03b2\/\u03b3 as an Exercise Mimetic: Potential Therapeutic Applications].<\/title><secondary-title>Revista medica de Chile<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.4067\/s0034-98872026000200237<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.4067\/s0034-98872026000200237<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Weiyi Xu<\/author><author>Cyrielle Billon<\/author><author>Hui Li et al.<\/author><\/authors><\/contributors><titles><title>Abstract 9682: The Cardiac Protective Effects of Novel Synthetic Pan-Estrogen Related Receptor Agonists Slu-pp-332 and Slu-pp-915<\/title><secondary-title>Circulation<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1161\/circ.144.suppl_1.9682<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Bonanni R<\/author><author>Falvino A<\/author><author>Matticari A et al.<\/author><\/authors><\/contributors><titles><title>Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study.<\/title><secondary-title>Frontiers in physiology<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.3389\/fphys.2025.1616693<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2025.1616693\/full<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Billon C<\/author><author>Schoepke E<\/author><author>Avdagic A et al.<\/author><\/authors><\/contributors><titles><title>A Synthetic ERR Agonist Alleviates Metabolic Syndrome.<\/title><secondary-title>The Journal of pharmacology and experimental therapeutics<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1124\/jpet.123.001733<\/electronic-resource-num><urls><related-urls><url>https:\/\/jpet.aspetjournals.org\/content\/jpet\/early\/2023\/09\/22\/jpet.123.001733.full.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Xu W<\/author><author>Billon C<\/author><author>Li H et al.<\/author><\/authors><\/contributors><titles><title>Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial Function.<\/title><secondary-title>Circulation<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1161\/CIRCULATIONAHA.123.066542<\/electronic-resource-num><urls><related-urls><url>https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10842599\/pdf\/nihms-1941033.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>R\u00f6dlistade arter i Sverige 2025<\/title><secondary-title>SLU Artdatabanken rapporterar<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.54612\/a.6scftkgu7u<\/electronic-resource-num><urls><related-urls><url>https:\/\/pub.epsilon.slu.se\/id\/eprint\/39759\/contents<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mats S\u00f6derstr\u00f6m<\/author><author>Bruno Morandin Figueiredo et al.<\/author><\/authors><\/contributors><titles><title>Developments in proximal crop sensing for precision agriculture<\/title><secondary-title>Burleigh Dodds Series in Agricultural Science<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.19103\/as.2025.0152.02<\/electronic-resource-num><urls><related-urls><url>https:\/\/pub.epsilon.slu.se\/38800\/1\/soderstrom-m-et-al-20251111.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Doing More Good<\/author><author>SLU<\/author><author>Ger\u00e8ncia d'\u00c0rea d'Economia i Promoci\u00f3 Econ\u00f2mica<\/author><\/authors><\/contributors><titles><title>Conveni de col\u00b7laboraci\u00f3 entre l'Ajuntament de Barcelona i Doing More Good Slu per al projecte Congreso Europeo de Sports Business: Sportbiz Europe Barcelona<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><urls><related-urls><url>https:\/\/core.ac.uk\/download\/596352815.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Wang XX<\/author><author>Myakala K<\/author><author>Libby AE et al.<\/author><\/authors><\/contributors><titles><title>Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging Kidney.<\/title><secondary-title>The American journal of pathology<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1016\/j.ajpath.2023.07.008<\/electronic-resource-num><urls><related-urls><url>http:\/\/ajp.amjpathol.org\/article\/S0002944023003218\/pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Billon C<\/author><author>Appourchaux K<\/author><author>C\u00f4t\u00e9 I et al.<\/author><\/authors><\/contributors><titles><title>An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacity.<\/title><secondary-title>The Journal of pharmacology and experimental therapeutics<\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.1016\/j.jpet.2025.103787<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Sophia Collins<\/author><author>Amanda Kohne<\/author><author>Mary Otten et al.<\/author><\/authors><\/contributors><titles><title>SLU DOES: SLU Drones for Outreach and Education in STEM - A Framework for Community Engagement<\/title><secondary-title>AIAA SCITECH 2024 Forum<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.2514\/6.2024-0054<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>\u00c5rsber\u00e4ttelse 2025 : SLU Centrum f\u00f6r biologisk bek\u00e4mpning<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2026<\/year><\/dates><electronic-resource-num>10.54612\/a.70g1crqa39<\/electronic-resource-num><\/record>\n<\/records><\/xml>\n"